Myriad Genetics Inc
- Stock
- Ticker MYGN
- ISIN US62855J1043
- Nasdaq
Performance, volatility and drawdowns of Myriad Genetics Inc since 11/2016, with distributions reinvested and calculated in US dollars. As of 20 Nov 2026.
Performance
$10,000 grew to $3,182. Global equities (VT): $29,042.
Distributions reinvested, before taxes and brokerage costs. Dashed: Global equities (VT) for comparison.
Declines from the peak
Lowest point −94.3% in 07/2026, measured from the peak in 09/2018. The old peak has not been reached again yet.
Financial statements
Amounts in $ millions from filings with the SEC, earnings per share in $; fourth quarter and quarterly cash flow derived from year-to-date figures
| Quarter end | 12/2024 | 03/2025 | 06/2025 | 09/2025 | 12/2025 | 03/2026 | 06/2026 | 09/2026 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | 211 | 196 | 213 | 206 | 210 | 200 | 191 | 203 |
| Gross profit | 151 | 134 | 152 | 144 | 147 | 138 | 127 | 138 |
| Operating income | -39 | -29 | -329 | -23 | -5.7 | -31 | -39 | -40 |
| EBITDA | -24 | -15 | -324 | -19 | 6.9 | -18 | -34 | -35 |
| Net income | -43 | -0.1 | -331 | -27 | -7.9 | -34 | -43 | -44 |
| Earnings per share | -0.47 | 0.00 | -3.57 | -0.29 | -0.07 | -0.36 | -0.46 | -0.46 |
| Balance sheet | ||||||||
| Total assets | 1,028 | 1,006 | 677 | 728 | 707 | 674 | 639 | 609 |
| Liabilities | 327 | 301 | 289 | 355 | 339 | 336 | 335 | 340 |
| Equity | 701 | 705 | 388 | 373 | 368 | 337 | 304 | 269 |
| Cash | 102 | 92 | 74 | 145 | 150 | 124 | 115 | 107 |
| Long-term debt | 40 | 59 | 0.0 | 120 | 120 | 120 | 121 | 121 |
| Cash flow | ||||||||
| Operating cash flow | 6.6 | -16 | -14 | 21 | 11 | -16 | -8.3 | -6.5 |
| Free cash flow | 6.6 | -16 | -14 | 21 | 11 | -16 | -8.3 | -6.5 |
Value it:DCF calculatorMultiples calculator
Annual returns
Best year 2017 at +106.1%, weakest 2025 at −55.1%. 3 of 9 full years were positive. * partial year.
Quarterly reports
Filing date with the SEC and earnings per share of the quarter
| Day | Earnings per share |
|---|---|
| 6 Nov 2026 | −$0.46 |
| 31 Jul 2026 | −$0.46 |
| 6 May 2026 | −$0.36 |
| 24 Feb 2026 | −$0.07 |
| 4 Nov 2025 | −$0.29 |
| 6 Aug 2025 | −$3.57 |
| 7 May 2025 | $0.00 |
| 28 Feb 2025 | −$0.47 |
| 8 Nov 2024 | −$0.24 |
| 7 Aug 2024 | −$0.41 |
| 8 May 2024 | −$0.29 |
| 28 Feb 2024 | −$0.34 |
Key metrics
Metrics of 15 Nov 2026; P/E, P/B, P/S, market cap and dividend yield at the last close.
Valuation
- Market cap
- €475m
- Market cap in trading currency
- $524m
- Enterprise value
- $538m
- P/E
- –
- P/S
- 0.65
- P/B
- 1.95
- EV/Sales
- 0.67
- EV/EBITDA
- –
- Earnings yield
- –
- FCF yield
- -3.8%
Results (last four quarters)
- Revenue
- $804m
- Gross profit
- $549m
- EBITDA
- −$80.4m
- Net income
- −$129m
- Earnings per share
- −$1.35
- Revenue per share
- $8.38
- Revenue growth
- −1.5%
- Earnings growth
- –
Profitability
- Gross margin
- 68.3%
- Operating margin
- -14.3%
- Net margin
- -16.1%
- Return on equity
- -40.2%
- Return on assets
- -21.2%
Balance sheet and cash flow
- Cash
- $107m
- Cash per share
- $1.12
- Financial debt
- $121m
- Debt/equity %
- 45
- Current ratio
- 1.98
- Book value per share
- $2.80
- Operating cash flow
- −$19.9m
- Free cash flow
- −$19.9m
Dividend
- Dividend yield
- 0.00%
- Dividend (12 months)
- $0.00
- Yield (12 months)
- 0.00%
- Payout ratio
- –
- Ex-dividend date
- –
Shares and trading
- Shares outstanding
- 95.9m
- Volume
- 1.25m
- Avg. volume 3 months
- 2.32m
- Relative volume
- 0.5
Price and technicals
- Price
- $5.46
- 1 day
- −1.4%
- 52-week high
- $7.91
- 52-week low
- $2.86
- Distance to 52-week high
- −31.0%
- Distance to 52-week low
- +90.9%
- Distance to 50-day line
- +9.7%
- Distance to 200-day line
- +18.4%
- RSI (14)
- 49
- Volatility 1M
- 54.3%
Performance
- 1 week
- −3.5%
- 1 month
- −5.2%
- 3 months
- +79.0%
- 6 months
- +42.9%
- YTD
- −11.2%
- 1 year
- −15.2%
Dates
- Fiscal year end
- 31 Dec 2025
- Most recent quarter
- 30 Sep 2026
Frequently asked questions
How has MYGN performed since 11/2016?
$10,000 grew to $3,182 by 20 Nov 2026, which is −10.8% per year. Distributions are reinvested; taxes and brokerage costs are not deducted.
How volatile is MYGN?
Volatility was 64.4% per year, measured on monthly returns. The largest decline from a peak was −94.3%, with the low in 07/2026.
How does MYGN compare with a broad equity ETF?
Over the same period Global equities (VT) returned +11.3% per year at 15.1% volatility, MYGN returned −10.8% at 64.4%. The correlation of monthly returns was 0.38; 1 would mean they moved in lockstep.
Which currency are the figures in?
In US dollars, the currency of the US listing.